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Purpose: To determine the maximum rate of false-positive diag-
noses that patients and health care professionals were 
willing to accept in exchange for detection of extracolonic 
malignancy by using computed tomographic (CT) colonog-
raphy for colorectal cancer screening.
Materials and 
Methods:
After obtaining ethical approval and informed consent, 52 
patients and 50 health care professionals undertook two 
discrete choice experiments where they chose between un-
restricted CT colonography that examined intra- and extra-
colonic organs or CT colonography restricted to the colon, 
across different scenarios. The first experiment detected 
one extracolonic malignancy per 600 cases with a false-
positive rate varying across scenarios from 0% to 99.8%. 
One experiment examined radiologic follow-up generated 
by false-positive diagnoses while the other examined inva-
sive follow-up. Intracolonic performance was identical for 
both tests. The median tipping point (maximum accept-
able false-positive rate for extracolonic findings) was cal-
culated overall and for both groups by bootstrap analysis.
Results: The median tipping point for radiologic follow-up occurred 
at a false-positive rate greater than 99.8% (interquartile 
ratio [IQR], 10 to .99.8%). Participants would tolerate 
at least a 99.8% rate of unnecessary radiologic tests to 
detect an additional extracolonic malignancy. The median 
tipping-point for invasive follow-up occurred at a false-
positive rate of 10% (IQR, 2 to .99.8%). Tipping points 
were significantly higher for patients than for health care 
professionals for both experiments (>99.8 vs 40% for ra-
diologic follow-up and >99.8 vs 5% for invasive follow-up, 
both P < .001).
Conclusion: Patients and health care professionals are willing to 
tolerate high rates of false-positive diagnoses with CT 
colonography in exchange for diagnosis of extracolonic 
malignancy. The actual specificity of screening CT colo-
nography for extracolonic findings in clinical practice is 
likely to be highly acceptable to both patients and health 
care professionals.
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Materials and Methods
Ethical committee approval was grant-
ed. All participants gave written in-
formed consent. Opinions were elicited 
by using a discrete choice experiment 
where participants chose between two 
alternatives. Each alternative has char-
acteristics (ie, attributes: sensitivity or 
discomfort) that are presented at dif-
ferent levels (eg, sensitivity 80%, 85%, 
90%) during the experiment. Repeating 
the choice task with systematic varia-
tion of the levels allowed the relative 
importance of each attribute to be 
quantified (16). Since discrete choice 
experiments are difficult to adminis-
ter via postal questionnaires (17), we 
used face-to-face interviews primar-
ily, providing background information 
for participants via interactive laptop 
presentation.
Recruitment
Consecutive adults of CRC screening 
age (55–69 years) who were sched-
uled to attend for unrelated ultraso-
nographic (US) investigations were 
identified by using a booking system. A 
research assistant mailed information 
and consent forms beforehand, and 
responders were interviewed on their 
appointment day. Individuals with a 
history of CRC or who underwent in-
vestigations for possible CRC were ex-
cluded to avoid bias (18). Additionally, 
harm is important because further 
tests precipitated by extracolonic find-
ings are common, occurring in 7%–
11% of people who are screened after 
CT colonography (2–9). One series 
estimated average costs for additional 
tests at just under $100 per patient 
screened (6). However, evidence sug-
gests that more asymptomatic cancers 
are detected beyond the colon than 
within it: a retrospective study (10) 
of 10 286 screened patients found that 
CT colonography depicted extracolonic 
malignancies in 0.35% versus CRC in 
0.21%.
The benefits or otherwise of ex-
tracolonic imaging has been debated 
widely (11,12), and neither clinicians 
(13) nor policy makers (14) are clear 
about whether it is helpful or not 
for population screening. Further-
more, little research has investigated 
whether clinicians or their patients re-
gard extracolonic imaging as desirable. 
Specifically, it is unclear how individual 
patients and health care professionals 
balance the possibility of detecting 
life-threatening extracolonic patho-
logic findings against the larger chance 
of fruitless (or even harmful) testing 
precipitated by extracolonic findings. 
While qualitative studies have found 
that screening-age patients generally 
view the ability of CT colonography to 
visualize extracolonic organs as advan-
tageous (15), we do not know at what 
point (if at all) perceived benefit is out-
weighed by the inconvenience, worry, 
and risks of unnecessary further in-
vestigation. We therefore aimed to 
determine the maximum rate of false-
positive diagnoses that patients and 
health care professionals were willing 
to accept in exchange for detection of 
extracolonic malignancy by using CT 
colonography for CRC screening.
D iagnostic tests used for cancer screening programs usually tar-get a specific organ. However, 
when screening for colorectal cancer 
(CRC) by using computed tomographic 
(CT) colonography, extracolonic ab-
dominal and pelvic tissues are imaged 
unavoidably, which potentially detects 
disease in organs other than the pri-
mary target. For example, a systematic 
review of 24 studies (1) estimated that 
approximately 20% of indeterminate 
renal masses detected with CT colo-
nography ultimately were malignant. 
While some of these findings are clin-
ically important, the majority are not. 
For example, the same systematic re-
view (1) estimated false-positive diag-
noses of extracolonic malignancy with 
CT colonography in 4.6% of men and 
6.8% of women. Clarification often re-
quires further investigations, including 
biopsy and even surgery, which may 
be worrisome, costly, and occasionally 
harmful, all for no ultimate benefit in 
most patients. Balancing benefit and 
Implication for Patient Care
 n The false-positive rate of 
screening CT colonography for 
extracolonic findings in current 
clinical practice is likely to be 
highly acceptable to both 
patients and health care 
professionals.
Advances in Knowledge
 n Patients and health care profes-
sionals were highly tolerant of 
false-positive diagnoses that led 
to additional, unnecessary radio-
logic testing subsequent to CT 
colonography, up to a median 
false-positive rate greater than 
99.8% (interquartile ratio [IQR], 
10 to .99.8%).
 n Patients and health care profes-
sionals were highly tolerant of 
false-positive diagnoses that led 
to additional, unnecessary inva-
sive testing (eg, biopsy, endos-
copy, and surgery) subsequent to 
CT colonography, up to a median 
false-positive rate of 10% (IQR, 2 
to .99.8%).
 n Patients were significantly more 
tolerant of false-positive diag-
noses of extracolonic malignancy 
by CT colonography than were 
health care professionals, for 
both those that generated subse-
quent radiologic tests and those 
that generated subsequent inva-
sive tests.
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and by using text and included both ab-
solute risks and natural frequencies to 
maximize patient understanding (21,22) 
(Fig 1). Patients were told to assume 
they were asymptomatic and at average 
risk of both intracolonic and extraco-
lonic pathologic findings and to pick the 
test they would choose for themselves 
or a close friend or relative, with no 
opt-out. Health care professionals were 
asked to pick the test they felt was best 
suited to population screening (rather 
than for their own care). The radio-
logic testing experiment was performed 
first, followed by the invasive testing 
experiment.
For each experiment, the different 
false-positive rates for unrestricted CT 
colonography were presented in a non-
sequential order (ie, the rate did not 
increase or decrease incrementally). 
One choice was repeated to test con-
sistency. If inconsistent, the response 
was clarified with the participant; the 
second response was used for online 
participants. Unrestricted CT colo-
nography was also presented with a 
zero false-positive rate, and those who 
chose restricted CT colonography in 
this scenario were labeled as irrational 
responders. If this occurred, the rea-
son for choosing restricted CT colo-
nography was recorded after qualita-
tive exploration, but the response was 
retained for the subsequent analysis. 
Participants who preferred unre-
stricted CT colonography despite a 
false-positive rate of 599 of 600 cases 
in the invasive testing scenario were 
presented with additional information 
that emphasized potential harms (in-
cluding death) that could arise from 
this situation. The risk of death was 
stated as one in 600 cases (23); par-
ticipants were therefore choosing be-
tween a one-in-600 chance of early ex-
tracolonic malignancy diagnosis versus 
an equivalent risk of death plus the 
near certainty of unnecessary addi-
tional invasive procedures.
Pilot Testing
To confirm comprehensibility, estimate 
completion time, and inform sample 
size, 15 individuals (10 professionals 
and five patients) were piloted (data 
Participants were told that tests for 
false alarms were unnecessary because 
the patient derived no benefit from the 
ultimate diagnosis, the hypothetical 
population being tested was asymp-
tomatic, and the focus was purely on 
findings outside the colon.
We presented two hypothetical 
tests: unrestricted CT colonography 
evaluated both the colon and extraco-
lonic organs, and restricted CT colo-
nography was confined to the colon. 
Participants were told that diagnostic 
accuracy for colonic neoplasia was iden-
tical for both tests (5). Unrestricted CT 
colonography was assumed to depict 
extracolonic malignancy at an early 
and curable stage in one in 600 cases 
(a conservative estimate derived from 
the literature [10]), whereas restricted 
CT colonography did not. Participants 
were told that the impact of early diag-
nosis on overall survival was unknown, 
and that even by using unrestricted CT 
colonography, many extracolonic ma-
lignancies would remain undetected 
by a one-off screening examination (ie, 
detection did not necessarily result in 
cure). Across the scenarios presented, 
the specificity (depicted as a false-posi-
tive rate) of unrestricted CT colonogra-
phy varied from 100% to 0.17%, corre-
sponding to a rate of additional testing 
that ranged from none to 599 extra 
tests to diagnose one extracolonic ma-
lignancy per 600 patients (Table 1). The 
invasive testing experiment included a 
scenario where the chance of death was 
directly equivalent to the chance of ex-
tracolonic malignancy diagnosis, and it 
had the additional disadvantage of the 
near-certainty of an unnecessary inva-
sive procedure.
Experiment Format
Background information regarding 
CRC, screening, CT colonography, and 
risk was presented by using a multi-
media presentation. Consequences of 
false-positive results were described in 
terms of need for additional imaging or 
biopsy (eg, resection of indeterminate 
ovarian cysts). We explained the nature 
of needle, endoscopic, and surgical ex-
cision biopsy. The chance of requiring 
an extra test was presented graphically 
radiologists, colorectal surgeons, gas-
troenterologists, specialist nurses, 
and radiographers who requested, 
performed, or interpreted colorectal 
imaging were recruited via hospital e-
mail. Participants were offered a £10 
voucher. Because a previous study 
found no difference for health care 
professionals between online and face-
to-face completion (19), this group 
could complete the experiment online. 
All patient participants were inter-
viewed in person by either radiology 
research fellows (A.A.P., D.B., E.H.), 
or research assistants (H.F., N.B.).
Attributes
The focus of this study was extraco-
lonic false-positive diagnosis with CT 
colonography at CRC screening, de-
scribed to participants as false alarms. 
While some extracolonic findings 
are fully characterized by using ad-
ditional imaging (eg, US for indeter-
minate renal lesions), others require 
invasive tests (endoscopy, biopsy, or 
surgery). To address both situations, 
participants undertook two separate 
experiments. In the first experiment 
(radiologic testing), participants were 
told that false-positive extracolonic di-
agnosis would precipitate unnecessary 
further imaging. Participants were in-
structed to assume the rates of such 
imaging to be 50% US, 45% CT, and 
5% magnetic resonance (MR) imag-
ing, per published literature (6). Dis-
advantages of imaging were explained 
as follows: US and MR imaging were 
described as safe, but might cause in-
convenience and anxiety. Noise and 
claustrophobia were described for MR 
imaging. CT was described as includ-
ing a very small chance of cancer in-
duction several years afterward (20). 
In the second experiment (invasive 
testing), false-positive diagnoses led 
to biopsy, endoscopy, or surgery. Par-
ticipants were instructed to assume 
that approximately 50% of invasive 
tests would be surgical, 25% would be 
needle biopsy (either fine-needle as-
piration or core), and 25% would be 
endoscopy (6). Pain, bleeding, perfo-
ration, and a small risk of death were 
mentioned as possible complications. 
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Analysis
The primary outcome measure was the 
maximum false-positive rate that the av-
erage participant was willing to accept 
in exchange for a one-in-600 chance of 
diagnosing an extracolonic malignancy, 
or the so-called tipping point. The pilot 
suggested a mean acceptable false-posi-
tive rate of 11% for invasive testing with 
a standard deviation of 0.23. To deter-
mine the mean tipping point with 95% 
confidence intervals at a two-sided a 
level of .05 and 90% power required 81 
participants and used the following equa-
tion: [n = 4s2(zcrit)
2/D2], where D = 0.10, 
s = 0.23, and zcrit = 1.960 (24). Because 
pilot data were not normal, we aimed to 
recruit a further 15% of participants (ie, 
81 + 0.15 × 81 = minimum of 93 partic-
ipants in total). A prespecified second-
ary outcome to compare subgroups of 
patients versus health care professionals 
required 56 participants each for 90% 
power to detect a 20% difference in the 
maximum false-positive rate.
The overall median tipping point 
for participants was calculated for 
each experiment, and it was calculated 
individually for patients and profes-
sionals. Because numbers of patients 
and professionals differed, the overall 
tipping point was calculated by using 
2000 bootstrap estimates of medians 
and interquartile ranges with equally 
sized samples from each group (n = 50 
participants in each sample). Tip-
ping points were nonnormal and were 
therefore summarized with medians 
and interquartile ranges. Nontrad-
ers were defined as participants who 
consistently chose one test over the 
alternative across all of the scenarios 
presented. Nontraders were therefore 
regarded as requiring higher tipping-
points than were offered in the ex-
periment, but responses were still in-
cluded. The Mann-Whitney U test and 
Wilcoxon signed rank sum test were 
used for unpaired and paired compar-
isons respectively. Data were collated 
by using software (Microsoft Excel 
2011 for Mac v14.3.4; Microsoft, Red-
mond, Wash) and analyzed with sta-
tistical software (R version 2.15.1; R 
Foundation for Statistical Computing, 
Vienna, Austria) (25).
Table 1
Attributes and Levels Presented in the Radiologic Testing and Invasive Testing 
Experiments
a: radiologic Testing experiment
Radiologic Testing  
Question No.
False-Positive Rate,  
Unrestricted CT  
Colonography (%)
False-Positive Rate,  
Restricted CT  
Colonography (%) 
No. of Curable  
Extracolonic Cancers  
Detected with Unrestricted 
CT Colonography Per 600  
Screening Examinations
No. of Additional False-
Positive Detections 
with Unrestricted CT 
Colonography 
Per 600 Screening 
Examinations
Question 1r 0 0 1 0
Question 2r 0.17 0 1 1
Question 3r* 4 0 1 24
Question 4r* 4 0 1 24
Question 5r 10 0 1 60
Question 6r 20 0 1 120
Question 7r 40 0 1 240
Question 8r 60 0 1 360
Question 9r 80 0 1 480
Question 10r† 99.8 0 1 599
B: invasive Testing experiment
Invasive Testing  
Question No.
False-Positive Rate,  
Unrestricted CT  
Colonography (%)
False-Positive Rate,  
Restricted CT  
Colonography (%) 
No. of Curable  
Extracolonic Cancers  
Detected with Unrestricted 
CT Colonography Per 600  
Screening Examinations
No. of Additional False-
Positive Detections  
with Unrestricted CT 
Colonography Per 600 
Screening  
Examinations
Question 1i 0 0 1 0
Question 2i 0.17 0 1 1
Question 3i* 1 0 1 6
Question 4i* 1 0 1 6
Question 5i 2 0 1 12
Question 6i 4 0 1 24
Question 7i 10 0 1 60
Question 8i 20 0 1 120
Question 9i 40 0 1 240
Question 10i 60 0 1 360
Question 11i 80 0 1 480
Question 12i 99.8 0 1 599
Question 13i‡ 99.8 0 1 599§
Note.—Unrestricted CT colonography shows the inside and outside of the colon, while restricted CT colonography only shows 
the inside of the colon.
* Questions are identical to test for internal consistency.
† Participants who chose unrestricted CT colonography in response to question 10 were considered nontraders.
‡ Participants who chose unrestricted CT colonography in response to question 13 were considered nontraders.
§ One death.
not included in the final analysis). This 
confirmed that attributes and levels, 
and the concept of choosing between 
two scenarios (ie, trading test benefits 
vs harms) were comprehensible. How-
ever, simultaneous consideration of 
false-positive diagnoses that led to both 
radiologic follow-up and invasive testing 
was judged as too confusing, which ex-
plained why these were presented ul-
timately as separate experiments (see 
Appendix E1 [online]).
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Figure 1
Figure 1: Example from the invasive testing experiment. A hypothetical screening population of 600 
individuals was presented and participants were invited to choose between a test that generated a variable rate 
of false-positive diagnoses (pink) with a one-in-600 chance of finding an early-stage extracolonic malignancy 
(green) or a test that generated no false-positive diagnoses but had no chance of finding an extracolonic 
malignancy (yellow). Participants were informed that their chance of receiving any particular result could not be 
predicted in advance and was essentially random. Relative and absolute percentages were presented. This im-
age corresponds to the median tipping point for patients and professionals combined: on average, unrestricted 
CT colonography (Test A on the Figure) was preferred to this level of false-positive invasive tests, but not beyond.
Results
We invited 318 patients and 96 health 
care professionals. Of these, 79 patients 
participated (24.8%) but only 52 were 
interviewed because of scheduling con-
flicts. Fifty health care professionals par-
ticipated (a response rate of 52.1%), 21 
(42.0%) were interviewed face to face, 
and 29 (58.0%) responded online. On 
average, patients were older than pro-
fessionals (median, 64.5 years vs 29.5 
years; P , .001) and had discontinued 
education earlier (50.0% educated to at 
least bachelor’s degree level vs 94.0%; P 
, .001; Table 2). There were no signifi-
cant differences in sex ratio (P = .54) or 
ethnicity (P = .14).
Nontraders
For the radiologic testing experiment, 
61 of the 102 participants interviewed 
(59.8%; 41 patients, 20 professionals) 
were deemed nontraders (ie, they al-
ways chose unrestricted CT colonog-
raphy), 24 of whom (23.5% overall; 
23 patients, one professional) were 
also nontraders for the invasive test-
ing experiment. These 24 nontrad-
ers felt unable to choose restricted 
CT colonography despite that one 
scenario for unrestricted CT colo-
nography presented a risk of death 
equivalent to the chance for detection 
of an extracolonic malignancy. Con-
versely, a single patient participant 
never chose unrestricted CT colonog-
raphy (even for the zero false-positive 
scenario), stating a firm opinion that 
CRC screening should examine the 
colon alone. On average, nontraders 
were significantly older (median age, 
nontraders vs traders, 64.5 years vs 
29.5 years, respectively; P , .001), 
significantly more likely to be pa-
tients (41 patients [67.2%] vs 20 pro-
fessionals [32.8%]; P , .001), and 
were less educated than traders (at 
least bachelor’s degree–level educa-
tion, nontraders vs traders, 38 of 61 
[62.3%] vs 35 of 41 [85.4%] respec-
tively; P < .01). There was no signifi-
cant difference in sex (men, nontrad-
ers vs traders, 32 of 61 [52.5%] vs 24 
of 41 [58.5%] respectively; P = .55)
or ethnicity (whites, nontraders vs 
traders, 48 of 61 [78.7%] vs 28 of 41 
[68.3%] respectively, P = 0.24).
Radiologic Testing Discrete Choice 
Experiment
When the consequence of extracolonic 
findings was radiologic testing, the me-
dian tipping point occurred at a false-
positive rate of greater than 99.8% (in-
terquartile range [IQR], 10 to .99.8%; 
Table 3). Thus, the average participant 
was prepared to tolerate at least a 
99.8% rate of unnecessary additional 
radiologic tests to diagnose a single ad-
ditional extracolonic malignancy. The 
median tipping point was significantly 
higher for patients than professionals 
at greater than 99.8% (IQR, .99.8% 
to .99.8%) versus 40% (IQR, 10% to 
.99.8%; P , .001; Table 3). Overall, 
at a prevalence of one in 600 for poten-
tially curable extracolonic malignancy, 
this corresponds to more than 599 
unnecessary additional radiologic tests 
(IQR, 60 to .599) to find one curable 
extracolonic malignancy. Patients were 
prepared to accept a significantly higher 
number of false-positive diagnoses (me-
dian, .599; IQR, .599 to .599; Table 
3, Fig 2a) than were professionals (me-
dian, 240; IQR, 60 to .599; P , .001; 
Table 3, Fig 2b).
Invasive Testing Discrete Choice 
Experiment
When the consequence of extracolonic 
findings was invasive, the median tip-
ping point occurred at a false-positive 
rate of 10% (IQR, 2% to .99.8%). 
Thus, the average participant was 
prepared to tolerate a 10% rate of 
unnecessary additional invasive tests 
in exchange for diagnosis of a single 
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Table 3
Tipping Points and Number of False-Positive Diagnoses Deemed Acceptable in Each 
Scenario for Patients, Professionals, and the Two Groups Combined
Tipping Point (%)
Average No. Additional False- 
Positive Diagnoses Tolerated Per 
Additional  
Extracolonic Cancer Found
Parameter Median IQR Median IQR
Patients
 Scans .99.8 .99.8 to .99.8 .599 .599 to .599
 Invasive tests .99.8 20 to .99.8 .599 120 to .599
Professionals
 Scans 40 10 to .99.8 240 60 to .599
 Invasive tests 5 2–10 30 12–60
Combined
 Scans .99.8 10 to .99.8 .599 60 to .599
 Invasive tests 10 2 to .99.8 60 12 to .599
Table 2
Demographic Characteristics of Patient and Professional Participants
Characteristic Patients* Professionals† No. of Participants‡
Sex
 Male 27 (52) 29 (58) 56 (55)
 Female 25 (48) 21 (42) 46 (45)
Age (y)
 ,25 0 (0) 1 (2) 1 (1)
 25–34 0 (0) 31 (62) 31 (30)
 35–54 0 (0) 18 (36) 18 (18)
 55–59 1 (2) 0 (0) 1 (1)
 60–69 51 (98) 0 (0) 51 (50)
Ethnicity
 White 42 (81) 34 (68) 76 (75)
 Other 10 (19) 16 (32) 26 (25)
Education level
  Bachelor’s degree 26 (50) 47 (94) 73 (72)
 Other 26 (50) 3 (6) 29 (28)
Note.—Data in parentheses are percentages.
* n = 52.
† n = 50. Professionals consisted of 10 radiologists, five gastroenterologists, four surgeons, 19 registrars in these specialties, 
two specialist colorectal nurses, and 10 radiographers.
‡ n = 102.
extracolonic malignancy. The median 
tipping point was significantly high-
er for patients than professionals at 
greater than 99.8% (IQR, 20% to 
.99.8%) versus 5% (IQR, 2%–10%; P 
, .001; Table 3), respectively. Over-
all, at population prevalence of one in 
600, this corresponds to 60 (IQR, 12 
to . 599) additional invasive tests per 
extracolonic malignancy. Again, pa-
tients were prepared to tolerate higher 
numbers of false-positive diagnoses 
(median . 599, IQR 120 to . 599 plus 
risk of death; Table 3, Fig 3a) than 
professionals (median 30, IQR 12–60, 
P , .001; Table 3, Fig 3b).
The median number of false-posi-
tive diagnoses tolerated per extracolon-
ic malignancy was significantly higher 
for the radiologic testing than the in-
vasive testing experiment (P , .001), 
which demonstrated that additional im-
aging tests were deemed more accept-
able than additional invasive tests.
There was no significant difference 
in the median tipping points for patients 
interviewed by either radiologists or re-
search assistants (P = .57) or between 
professionals who gave their responses 
online as opposed to face-to-face inter-
views (P = .81).
Discussion
Extracolonic findings at CT colonogra-
phy present a clinical dilemma: Early 
diagnosis of important pathologic find-
ings might be curative, but unnecessary 
investigation of ultimately irrelevant 
findings has physical, psychologic, and 
financial costs. How patients and health 
care professionals balance these costs 
is not known with precision, hence our 
decision to conduct these experiments. 
We found that patients were prepared 
to tolerate an extremely high rate 
(.99.8%) of unnecessary additional 
imaging or invasive tests subsequent to 
screening CT colonography to reap the 
potential benefits of finding early-stage 
extracolonic malignancy. While health 
care professionals were less tolerant of 
unnecessary follow-up testing than pa-
tients, nevertheless we were surprised 
by the very high rates they accepted; 
on average, 40% was deemed accept-
able for radiologic follow-up. Invasive 
tests were deemed less acceptable by 
health care professionals, with the me-
dian tipping point at 5%. Nevertheless, 
these rates are substantially greater 
than occur in published series, where 
approximately 7%–11% of individuals 
required further diagnostic testing af-
ter CT colonography, and only 1%–2% 
required an invasive test (6). There-
fore, our data suggest that the spec-
ificity of screening CT colonography 
for extracolonic malignancy in current 
clinical practice is likely to be highly 
acceptable to both patients and health 
care professionals.
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Our data, while framed in the 
context of CRC screening, potentially 
have wider implications for incidental 
findings discovered with other imag-
ing modalities. Such so-called inciden-
talomas are common in CT urography 
(27), CT coronary angiography (28), 
thoracic CT when screening for lung 
cancer (29), and abdominopelvic CT 
and were the subject of the Ameri-
can College of Radiology white paper 
for management guidance (30). Our 
colonography for CRC screening found 
patients would tolerate over 4000 false-
positive diagnoses to avoid a single 
missed CRC (19); the issue of extra-
colonic malignancy was not examined. 
We found patients equally tolerant in 
the context of extracolonic malignancy, 
which confirmed that potentially life-
saving detection of pathologic findings 
outweighs the perceived disadvantages 
of subsequent testing irrespective of 
the organ being evaluated.
Previous studies that quantified 
patients’ perceptions of false-positive 
diagnoses have shown an overwhelm-
ing preference for improved sensitivity 
despite the costs of diminished speci-
ficity. When considering breast cancer 
screening with mammography, one 
study (26) found that 63% of women 
were prepared to accept 500 or more 
additional false-positive mammograms 
to save a single life by early breast can-
cer diagnosis. Similarly, a study of CT 
Figure 2
Figure 2: Cumulative plot of tipping points expressed as absolute numbers of additional unnecessary tests for (a) patients and (b) professionals in the radio-
logic testing experiment. Each gray dot shows an individual’s tipping point. Large red square shows the median value, corresponding to an average participant. 
Blue squares show 25 and 75 percentage points. FP = false positive.
Figure 3
Figure 3: Cumulative plot of tipping points expressed as numbers of additional unnecessary tests for (a) patients and (b) professionals in the invasive testing 
experiment. Each gray dot shows an individual’s tipping point. Large red square shows the median value, corresponding to an average participant. Blue squares show 
25 and 75 percentage points. FP = false positive.
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and it is possible that responses may 
have been different if patients were 
responsible for these costs; the exper-
iments were performed in the English 
National Health Service where patients 
do not bear costs directly. Finally, we 
studied outpatients attending hospital 
for unrelated investigations, who may 
not fully represent an unselected screen-
ing population.
In summary, by using discrete 
choice experiments we found that both 
patients and health care professionals 
believe diagnosis of extracolonic malig-
nancy with screening CT colonography 
greatly outweighs the potential disad-
vantages of subsequent radiologic or 
invasive investigation precipitated by 
false-positive diagnoses. This belief was 
held more strongly by patients than 
health care professionals. The specific-
ity of CT colonography for extracolonic 
malignancy in clinical practice is likely 
to be highly acceptable to both patients 
and health care professionals.
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